These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pediatric Subacute Sclerosing Panencephalitis: A Narrative Review on Measles and the Future of Vaccination. Sulaiman SA; Vora NM; Chhabra K; Bashir MA; Awan Z J Child Neurol; 2024 Mar; 39(3-4):89-97. PubMed ID: 38477320 [TBL] [Abstract][Full Text] [Related]
28. Increasing incidence of subacute sclerosing panencephalitis in infants: a collateral effect of under-vaccination. Pittet LF; Posfay-Barbe KM Clin Microbiol Infect; 2020 Jun; 26(6):662-664. PubMed ID: 32088332 [No Abstract] [Full Text] [Related]
29. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore. Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110 [TBL] [Abstract][Full Text] [Related]
30. Measles: summary of worldwide impact. Assaad F Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998 [TBL] [Abstract][Full Text] [Related]
31. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies]. Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552 [No Abstract] [Full Text] [Related]
32. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702 [TBL] [Abstract][Full Text] [Related]
33. Measles immunization in Iran. Mirchamsy H Rev Infect Dis; 1983; 5(3):491-4. PubMed ID: 6348917 [TBL] [Abstract][Full Text] [Related]
34. Measles and mumps immunization: benefit versus risk factors. Krugman S Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672 [TBL] [Abstract][Full Text] [Related]
35. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053 [TBL] [Abstract][Full Text] [Related]
36. Measles and subacute sclerosing panencephalitis. An argument for intensified vaccination in Australia. Robbins SJ Med J Aust; 1984 Sep; 141(6):325-7. PubMed ID: 6503814 [No Abstract] [Full Text] [Related]
37. Measles vaccination and risk of SSPE. Agarwal RK Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848 [No Abstract] [Full Text] [Related]
38. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976. Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Sato T; Isomura S; Ueda S; Kitamura I; Kaji M Biken J; 1978 Mar; 21(A):9-14. PubMed ID: 666722 [TBL] [Abstract][Full Text] [Related]
39. Measles: not just another viral exanthem. Duke T; Mgone CS Lancet; 2003 Mar; 361(9359):763-73. PubMed ID: 12620751 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland]. Gut W; Naruszewicz-Lesiuk D Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]